No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs73224979 |
chr21:45234151-45234152 |
Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs73906629 |
chr21:45234200-45234201 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs553979129 |
chr21:45234206-45234207 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs375576415 |
chr21:45234222-45234223 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs572475078 |
chr21:45234232-45234233 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs546265022 |
chr21:45234238-45234239 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs73906630 |
chr21:45234253-45234254 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs79651790 |
chr21:45234257-45234258 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs551608718 |
chr21:45234334-45234335 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs566304509 |
chr21:45234335-45234336 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs562053577 |
chr21:45234348-45234349 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs144137260 |
chr21:45234376-45234377 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs541250901 |
chr21:45234382-45234383 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs559877453 |
chr21:45234395-45234396 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs571428361 |
chr21:45234406-45234407 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs55825369 |
chr21:45234414-45234415 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs56177442 |
chr21:45234497-45234498 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs570404710 |
chr21:45234499-45234500 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs73906631 |
chr21:45234533-45234534 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs147341249 |
chr21:45234534-45234535 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs539221693 |
chr21:45234552-45234553 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs139456135 |
chr21:45234559-45234560 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs535723097 |
chr21:45234562-45234563 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs554042406 |
chr21:45234580-45234581 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs55663506 |
chr21:45234634-45234635 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
26 |
rs539596504 |
chr21:45234662-45234663 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs571464394 |
chr21:45234698-45234699 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs113618461 |
chr21:45234719-45234720 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs576421316 |
chr21:45234736-45234737 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs11089098 |
chr21:45234744-45234745 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
31 |
rs543181894 |
chr21:45234771-45234772 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs555313619 |
chr21:45234779-45234780 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs2838395 |
chr21:45234806-45234807 |
Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
34 |
rs541315056 |
chr21:45234815-45234816 |
Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs146323590 |
chr21:45234827-45234828 |
Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs374990889 |
chr21:45234828-45234829 |
Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs11909278 |
chr21:45234894-45234895 |
Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
38 |
rs540642214 |
chr21:45234912-45234913 |
Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs545231236 |
chr21:45235013-45235014 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs564220591 |
chr21:45235052-45235053 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs531404573 |
chr21:45235061-45235062 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs11909913 |
chr21:45235081-45235082 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs568045855 |
chr21:45235082-45235083 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs529247577 |
chr21:45235096-45235097 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs10854487 |
chr21:45235104-45235105 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs28392681 |
chr21:45235120-45235121 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs185727268 |
chr21:45235139-45235140 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs188987510 |
chr21:45235149-45235150 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs112844583 |
chr21:45235166-45235167 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs192811485 |
chr21:45235184-45235185 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|